Hospital
York General Hospital
York General Hospital was paid $2.38M by Medicaid between Jan 2018 and Nov 2024, across 59 billing codes. Its largest line is 99284, emergency room visit (serious) — 16% of everything it billed.
33Billing provider infoYORK GENERAL HOSPITAL
YORK, NE 68467
YORK, NE 68467
33aNPI1588764898assigned 09/25/2006
33bProvider typeCritical Access Hospital
28Total paid$2.38M
24GClaims44,105
24DCodes billed59
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Critical Access Hospital providers in Nebraska
Rank by total paid#5 of 53
Median peer was paid$593K
This provider vs. median4.0×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 3,991 | $180K | |
| 2019 | 5,229 | $266K | |
| 2020 | 5,063 | $290K | |
| 2021 | 12,860 | $666K | |
| 2022 | 13,237 | $747K | |
| 2023 | 3,510 | $205K | |
| 2024incomplete | 215 | $24K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 16% | 1,546 | 1,242 | $376K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 14% | 1,835 | 1,488 | $322K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 13% | 2,533 | 2,128 | $298K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 9.3% | 4,390 | 1,314 | $221K |
| 80050 | General health panel | 7.8% | 1,617 | 1,268 | $186K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 3.7% | 4,914 | 4,178 | $89K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 3.7% | 284 | 231 | $87K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 2.8% | 726 | 546 | $66K |
| J7030 | Infusion, normal saline solution , 1000 cc | 2.7% | 1,115 | 800 | $64K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 2.7% | 1,390 | 517 | $63K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 2.4% | 726 | 658 | $57K |
| 36415 | Collection of venous blood by venipuncture | 1.8% | 4,331 | 3,146 | $43K |
47 more codes
| 80053 | Comprehensive metabolic panel | 1.7% | 1,340 | $41K |
| J7120 | Ringers lactate infusion, up to 1000 cc | 1.7% | 632 | $40K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 1.5% | 378 | $36K |
| J3490 | Unclassified drugs | 1.4% | 1,426 | $34K |
| 81001 | 1.3% | 1,930 | $32K | |
| 84484 | 1.3% | 469 | $31K | |
| 71045 | Radiologic examination, chest; single view | 1.2% | 370 | $29K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.2% | 1,476 | $27K |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | <1% | 4,469 | $23K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | <1% | 236 | $21K |
| 86140 | <1% | 480 | $18K | |
| G0378 | Hospital observation service, per hour | <1% | 30 | $18K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 26 | $15K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 919 | $14K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 374 | $14K |
| 84145 | <1% | 230 | $13K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 590 | $11K |
| 83690 | <1% | 256 | $10K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 439 | $10K |
| 85027 | <1% | 541 | $9K | |
| 97161 | <1% | 260 | $8K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 317 | $7K |
| 83880 | <1% | 79 | $6K | |
| 82150 | <1% | 187 | $6K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 123 | $5K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 406 | $5K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 228 | $4K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 131 | $3K |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 32 | $2K |
| 85379 | <1% | 25 | $1K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 13 | $1K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 44 | $1K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 13 | $1K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 12 | $1K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 15 | $897.45 |
| 81025 | <1% | 17 | $764.40 | |
| A4657 | Syringe, with or without needle, each | <1% | 15 | $756.22 |
| 87807 | <1% | 12 | $664.56 | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 42 | $485.80 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 13 | $461.76 |
| 87210 | <1% | 12 | $410.28 | |
| 83605 | <1% | 17 | $381.47 | |
| 87077 | <1% | 12 | $342.37 | |
| 82550 | <1% | 19 | $327.57 | |
| 82553 | <1% | 17 | $318.99 | |
| 81015 | <1% | 12 | $266.76 | |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 0% | 14 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialULRICH, JAMES (CEO)
| Provider | Location | Paid |
|---|---|---|
| York General Hospital | York, NE | $18K |
| York General Hospital | York, NE | $17K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.